| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10833961 | Molecular Genetics and Metabolism | 2011 | 7 Pages |
Abstract
The results revealed that as a prognostic marker, Cystatin C is a good and cost effective indicator of early renal dysfunction and/or heart failure in FD. It is also more useful than serum creatinine in detecting mild renal damage and small decreases in glomerular filtration. In addition, the natriuretic peptide NT-proBNP, was elevated in patients with FD and cardiac involvement, and found to be an adequate detection marker, not only of cardiac involvement, but also of diastolic dysfunction.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Miguel-Ángel Torralba-Cabeza, Susana Olivera, Derralynn A. Hughes, Gregory M. Pastores, Ramón Nuviala Mateo, Juan-Ignacio Pérez-Calvo,